Intraoperative Therapeutic Plasma Exchange for Sensitized Heart Transplant Candidates
- 22 March 2026
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (2) , e70115
Abstract
Donor specific human leukocyte antigen antibodies are associated with increased risk of rejection, worse post‐transplant outcomes, and longer waitlist times due to the immunological risks. Intraoperative therapeutic plasma exchange (iTPE) represents a potential strategy to mitigate the immunological risk. This study aims to evaluate the clinical outcomes associated with the use of iTPE in sensitized heart transplant recipients. This retrospective, single‐center cohort study included 59 adult heart transplant recipients. Patients were categorized into three groups: those receiving iTPE ( n = 20), sensitized patients without iTPE ( n = 19), and unsensitized patients ( n = 20). We assessed recipient survival, antibody‐mediated rejection (AMR) and infection free survival, waitlist time, and length of intensive care unit (ICU) and hospital stay. The overall cohort had a median age of 58 years with predominantly female patients (61%). The iTPE group exhibited a higher percentage of donor specific antibody positive and positive flow cytometry crossmatch results. Unsensitized patients had shorter wait times, but there was no difference between the iTPE and sensitized groups. There was no statistically significant difference in ICU and hospital stay, one‐year and three‐year survival, and AMR‐free survival among the groups. The iTPE group had the lowest infection‐free survival at 1 year. In conclusion, we report that iTPE may serve as an effective adjunct to immunosuppressive therapy for higher immunological risk heart transplant recipients with comparable AMR‐free survival, 1‐ and 3‐year survival. However, increased susceptibility to infections with iTPE underscores the infection management strategies post‐transplant. Larger, multi‐center cohort studies are necessary.Keywords
This publication has 26 references indexed in Scilit:
- Modifications to therapeutic plasma exchange to achieve rapid exchange on cardiopulmonary bypass prior to pediatric cardiac transplantJournal of Clinical Apheresis, 2023
- Outcome of urgent desensitization in sensitized heart transplant recipientsJournal of the Formosan Medical Association, 2022
- The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report — 2021; Focus on recipient characteristicsThe Journal of Heart and Lung Transplantation, 2021
- The Waiting Game: Waitlist Times and Outcomes for Highly Sensitized Patients in the New Heart Transplant Allocation SystemThe Journal of Heart and Lung Transplantation, 2021
- Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting listThe Journal of Heart and Lung Transplantation, 2017
- Desensitization strategies in adult heart transplantation—Will persistence pay off?The Journal of Heart and Lung Transplantation, 2016
- Evolving experience of treating antibody-mediated rejection following lung transplantationTransplant Immunology, 2014
- Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2013
- HYPERACUTE REJECTION IN SINGLE LUNG TRANSPLANTATION???CASE REPORT OF SUCCESSFUL MANAGEMENT BY MEANS OF PLASMAPHERESIS AND ANTITHYMOCYTE GLOBULIN TREATMENTTransplantation, 2001
- The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology, 1993